UNG

UNG
  • 文章类型: Journal Article
    DNA中碱基的改变构成基因组不稳定性的主要来源。据信碱基改变引发碱基切除修复(BER),产生干扰DNA复制的DNA修复中间体。这里,我们显示基因组尿嘧啶,一种常见的碱基改变,诱导DNA复制应激(RS)而不被BER处理。在没有尿嘧啶DNA糖基化酶(UNG)的情况下,基因组尿嘧啶积累到高水平,DNA复制叉慢下来,PrimPol介导的再灌注增强,在新生DNA中产生单链缺口。UNG缺陷细胞中的ATR抑制阻断尿嘧啶诱导的间隙的修复,增加复制叉崩溃和细胞死亡。值得注意的是,一部分癌细胞上调UNG2以抑制基因组尿嘧啶并限制RS,这些癌细胞对ATR抑制剂和增加基因组尿嘧啶的药物共同治疗过敏。这些结果揭示了未加工的基因组尿嘧啶作为RS的意外来源和癌细胞的可靶向脆弱性。
    Alterations of bases in DNA constitute a major source of genomic instability. It is believed that base alterations trigger base excision repair (BER), generating DNA repair intermediates interfering with DNA replication. Here, we show that genomic uracil, a common type of base alteration, induces DNA replication stress (RS) without being processed by BER. In the absence of uracil DNA glycosylase (UNG), genomic uracil accumulates to high levels, DNA replication forks slow down, and PrimPol-mediated repriming is enhanced, generating single-stranded gaps in nascent DNA. ATR inhibition in UNG-deficient cells blocks the repair of uracil-induced gaps, increasing replication fork collapse and cell death. Notably, a subset of cancer cells upregulates UNG2 to suppress genomic uracil and limit RS, and these cancer cells are hypersensitive to co-treatment with ATR inhibitors and drugs increasing genomic uracil. These results reveal unprocessed genomic uracil as an unexpected source of RS and a targetable vulnerability of cancer cells.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    未经证实:两个支架/基质附着区(5'-和3'-MARsEµ)位于免疫球蛋白重链基因座(IgH)内的内含子核心增强子(cEµ)侧翼。除了它们在小鼠和人类中的保守性,MARsEµ的生理作用尚不清楚,其在体细胞超突变(SHM)中的参与从未得到深入评估.
    UNASSIGNED:我们的研究分析了缺乏MARsEµ的小鼠模型中的SHM及其转录控制,进一步结合到缺乏碱基切除修复和错配修复的相关模型。
    UNASSIGNED:我们在缺乏MARsEµ的动物中观察到了反向替代模式:SHM在cEµ上游降低,在cEµ下游增加。引人注目的是,由MARsEµ缺失诱导的SHM缺陷伴随着IgHV区有义转录的增加,排除直接转录偶联效应。有趣的是,通过繁殖到缺乏DNA修复的背景,我们展示了SHM缺陷,在此模型中从cEµ上游观察到,不是由于AID脱氨作用的减少,而是由于碱基切除修复相关的不忠实修复过程中的缺陷。
    UNASSIGNED:我们的研究指出了MARsEµ区域在将容易出错的修复机制限制在Ig基因位点的可变区域中的一个意想不到的“围栏”功能。
    Two scaffold/matrix attachment regions (5\'- and 3\'-MARsEµ ) flank the intronic core enhancer (cEµ) within the immunoglobulin heavy chain locus (IgH). Besides their conservation in mice and humans, the physiological role of MARsEµ is still unclear and their involvement in somatic hypermutation (SHM) has never been deeply evaluated.
    Our study analyzed SHM and its transcriptional control in a mouse model devoid of MARsEµ , further combined to relevant models deficient for base excision repair and mismatch repair.
    We observed an inverted substitution pattern in of MARsEµ -deficient animals: SHM being decreased upstream from cEµ and increased downstream of it. Strikingly, the SHM defect induced by MARsEµ -deletion was accompanied by an increase of sense transcription of the IgH V region, excluding a direct transcription-coupled effect. Interestingly, by breeding to DNA repair-deficient backgrounds, we showed that the SHM defect, observed upstream from cEµ in this model, was not due to a decrease in AID deamination but rather the consequence of a defect in base excision repair-associated unfaithful repair process.
    Our study pointed out an unexpected \"fence\" function of MARsEµ regions in limiting the error-prone repair machinery to the variable region of Ig gene loci.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    人尿嘧啶DNA糖基化酶(UNG2)是一种酶,其主要功能是从基因组DNA中去除尿嘧啶碱基。UNG2活性是至关重要的,当尿嘧啶碱基在DNA中在类别转换重组和体细胞超突变过程中升高时,此外,UNG2影响增加基因组尿嘧啶水平的胸苷酸合酶抑制剂的功效。这里,我们总结了UNG2及其线粒体类似物UNG1的酶学性质。为了促进对这些高度保守蛋白活性的研究,我们讨论了三种基于荧光的酶检测方法,这些方法为我们对UNG2功能的理解提供了很多信息。该测定法使用合成的DNA寡核苷酸底物,其中尿嘧啶碱基掺入DNA中,并且基板可以是单链的,双链,或形成其他结构,如DNA发夹或连接。以不同的方式检测UNG2报告尿嘧啶碱基切除的荧光信号:(1)通过变性PAGE可视化UNG2反应产物来测量尿嘧啶从末端标记的寡核苷酸中的切除;(2)通过将尿嘧啶与2-氨基嘌呤碱基配对在溶液中检测从dsDNA底物中的尿嘧啶切除,尿嘧啶切除后,其固有荧光增强;或(3)UNG2从发夹分子信标底物上切除尿嘧啶会改变底物的结构,并通过减轻荧光猝灭而打开荧光。除了它们在表征UNG2属性方面的效用之外,这些检测方法正被用于发现该酶的抑制剂,并确定蛋白质-蛋白质相互作用如何影响UNG2功能.
    Human uracil DNA glycosylase (UNG2) is an enzyme whose primary function is to remove uracil bases from genomic DNA. UNG2 activity is critical when uracil bases are elevated in DNA during class switch recombination and somatic hypermutation, and additionally, UNG2 affects the efficacy of thymidylate synthase inhibitors that increase genomic uracil levels. Here, we summarize the enzymatic properties of UNG2 and its mitochondrial analog UNG1. To facilitate studies on the activity of these highly conserved proteins, we discuss three fluorescence-based enzyme assays that have informed much of our understanding on UNG2 function. The assays use synthetic DNA oligonucleotide substrates with uracil bases incorporated in the DNA, and the substrates can be single-stranded, double-stranded, or form other structures such as DNA hairpins or junctions. The fluorescence signal reporting uracil base excision by UNG2 is detected in different ways: (1) Excision of uracil from end-labeled oligonucleotides is measured by visualizing UNG2 reaction products with denaturing PAGE; (2) Uracil excision from dsDNA substrates is detected in solution by base pairing uracil with 2-aminopurine, whose intrinsic fluorescence is enhanced upon uracil excision; or (3) UNG2 excision of uracil from a hairpin molecular beacon substrate changes the structure of the substrate and turns on fluorescence by relieving a fluorescence quench. In addition to their utility in characterizing UNG2 properties, these assays are being adapted to discover inhibitors of the enzyme and to determine how protein-protein interactions affect UNG2 function.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    几种市售的定量实时PCR(qPCR)系统能够高度灵敏地检测人DNA并提供降解指数(DI)以评估DNA质量。从法医遗传学的常规案例中,据观察,由于较长扩增子的扩增效率降低,法医样品(例如在次优条件下储存的血液样品)中的DNA降解导致在短串联重复标记(STR)的多重分析中的可见效应。进一步注意到,降解指数通常保持低于被认为是关键的值。因此,这项工作的目的是系统分析这种效应,并将常规qPCR检测方法与使用尿嘧啶DNA糖基化酶(UNG)的改良qPCR方法和基于电泳的DNA质量评估方法进行比较.将血液样品在三种不同的储存温度下储存长达316天。与在室温和4°C下储存的样品相比,在高温(37°C)下储存的样品观察到DNA回收率显着增加。我们观察到STR分析中降解的典型影响,但在任何储存条件下DI和储存时间之间都没有相关性。在本研究中使用的一种qPCR试剂盒中,添加UNG略微增加了检测DNA降解的灵敏度。当使用第二qPCR系统时,该观察结果未得到证实。电泳系统也未显示完整性值与时间之间的显着相关性。检测DNA降解的方法通常仅限于检测DNA片段化,我们得出结论,影响法医STR分型的退化更为复杂。
    Several commercially available quantitative real-time PCR (qPCR) systems enable highly sensitive detection of human DNA and provide a degradation index (DI) to assess DNA quality. From routine casework in forensic genetics, it was observed that DNA degradation in forensic samples such as blood samples stored under sub-optimal conditions leads to visible effects in multiplex analyses of short tandem repeat markers (STRs) due to decreased amplification efficiencies in longer amplicons. It was further noticed that degradation indices often remain below the value that is considered to be critical. Thus, the aim of this work was to systematically analyze this effect and to compare conventional qPCR assays with a modified qPCR approach using uracil DNA glycosylase (UNG) and DNA quality assessment methods based on electrophoresis. Blood samples were stored at three different storage temperatures for up to 316 days. Significantly increased DNA recovery was observed from samples stored at high temperatures (37 °C) compared samples stored at room temperature and 4 °C. We observed typical effects of degradation in STR analyses but no correlation between DI and storage time in any of the storage conditions. Adding UNG slightly increased the sensitivity of detecting DNA degradation in one of the qPCR kits used in this study. This observation was not confirmed when using a second qPCR system. Electrophoretic systems did also not reveal significant correlations between integrity values and time. Methods for detecting DNA degradation are usually limited to the detection of DNA fragmentation, and we conclude that degradation affecting forensic STR typing is more complex.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    高免疫球蛋白M(HIGM)综合征是一种罕见的抗体功能受损的免疫系统疾病。患者的临床表现根据潜在的遗传变异而变化。在这项研究中,我们在AID和UNG基因中发现了两个新的变异,与常染色体隐性遗传型HIGM有关,通过靶向下一代测序(NGS)小组。在一名36岁的患者中鉴定出活化诱导的胞苷脱氨酶(AID)基因编码序列中的双等位基因11个碱基对缺失(c.278_288delATGTGGCCGAC)。在40岁的患者中鉴定出尿嘧啶核苷糖基化酶(UNG)基因(c.924_925insGG)外显子7中的双等位基因两个碱基对插入。两种变体均通过Sanger测序证实。HIGM,像许多其他原发性免疫缺陷一样,是一种罕见且难以诊断的实体,具有异质性的临床表型。有早发型反复呼吸道感染史的患者应怀疑,淋巴结肿大,和自身免疫性疾病。诊断可能会延迟到成年,尤其是在微妙的情况下,或者由于缺乏意识而未将HIGM包括在鉴别诊断中。在这方面,基于NGS的诊断小组的基因检测为免疫缺陷患者的分子诊断提供了快速合理的工具,因此,缩短诊断和预防与发病率和死亡率增加相关的感染相关并发症的时间.
    Hyper immunoglobulin M (HIGM) syndrome is a rare disorder of the immune system with impaired antibody functions. The clinical picture of the patients varies according to the underlying genetic variation. In this study, we identified two novel variants in AID and UNG genes, which are associated with autosomal recessive type HIGM, by targeted next-generation sequencing (NGS) panel. A biallelic 11 base pair deletion (c.278_288delATGTGGCCGAC) in the coding sequence of activation-induced cytidine deaminase (AID) gene was identified in a 36-year-old patient. Biallelic two base pair insertion in exon 7 of uracil nucleoside glycosylase (UNG) gene (c.924_925insGG) was identified in a 40-year-old patient. Both variants were confirmed by Sanger sequencing. HIGM, like many of the other primary immunodeficiencies, is a rare and difficult-to-diagnose entity with heterogeneous clinical phenotypes. It should be suspected in patients with a history of early-onset recurrent respiratory infections, enlarged lymph nodes, and autoimmune disorders. There might be a delay in diagnosis until adulthood especially in subtle cases or if HIGM is not included in the differential diagnosis due lacking of awareness. In this regard, genetic testing with NGS-based diagnostic panels provide a rapid and reasonable tool for the molecular diagnosis of patients with immunodeficiencies and hence, decrease the time to diagnose and prevent infection-related complications associated with increased morbidity and mortality.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    CRISPR-Cas9技术的最新进展,特别是发现了基础和主要编辑,显著提高了我们对基因组进行精确改变的能力。我们假设调节某些内源性途径细胞可以改善这些编辑工具在哺乳动物细胞中的作用。我们建立了一个报告系统,其中一个小片段通过引物编辑(PE)整合到基因组中。有了这个系统,我们筛选了一个内部小分子文库,并鉴定了一组组蛋白去乙酰化酶抑制剂(HDACi)增加初免编辑.我们还发现HDACi提高了胞嘧啶碱基编辑(CBE)和腺嘌呤碱基编辑(ABE)的效率。此外,HDACi提高了胞嘧啶碱基编辑产品的纯度,伴随着尿嘧啶DNA糖基化酶(UNG)和UNG抑制剂(UGI)的乙酰化上调,并增强了它们的相互作用。总之,我们的工作表明,HDACi改善了Cas9介导的主要编辑和碱基编辑.
    Recent advances in CRISPR-Cas9 techniques, especially the discovery of base and prime editing, have significantly improved our ability to make precise changes in the genome. We hypothesized that modulating certain endogenous pathway cells could improve the action of those editing tools in mammalian cells. We established a reporter system in which a small fragment was integrated into the genome by prime editing (PE). With this system, we screened an in-house small-molecule library and identified a group of histone deacetylase inhibitors (HDACi) increasing prime editing. We also found that HDACi increased the efficiency of both cytosine base editing (CBE) and adenine base editing (ABE). Moreover, HDACi increased the purity of cytosine base editor products, which was accompanied by an upregulation of the acetylation of uracil DNA glycosylase (UNG) and UNG inhibitor (UGI) and an enhancement of their interaction. In summary, our work demonstrated that HDACi improves Cas9-mediated prime editing and base editing.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    暂无摘要。
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    Precise genome editing of human pluripotent stem cells (hPSCs) is crucial not only for basic science but also for biomedical applications such as ex vivo stem cell therapy and genetic disease modeling. However, hPSCs have unique cellular properties compared to somatic cells. For instance, hPSCs are extremely susceptible to DNA damage, and therefore Cas9-mediated DNA double-strand breaks (DSB) induce p53-dependent cell death, resulting in low Cas9 editing efficiency. Unlike Cas9 nucleases, base editors including cytosine base editor (CBE) and adenine base editor (ABE) can efficiently substitute single nucleotides without generating DSBs at target sites. Here, we found that the editing efficiency of CBE was significantly lower than that of ABE in human embryonic stem cells (hESCs), which are associated with high expression of DNA glycosylases, the key component of the base excision repair pathway. Sequential depletion of DNA glycosylases revealed that high expression of uracil DNA glycosylase (UNG) not only resulted in low editing efficiency but also affected CBE product purity (i.e., C to T) in hESCs. Therefore, additional suppression of UNG via transient knockdown would also improve C to T base substitutions in hESCs. These data suggest that the unique cellular characteristics of hPSCs could determine the efficiency of precise genome editing.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    噬菌体(噬菌体)已经进化出有效的手段来接管细菌宿主的机器。可用的分子工具可用于操纵细菌并随意转移分子途径。这里,我们描述了一种细菌生长抑制剂,基因产物T5.015,由T5噬菌体编码。细菌突变体基因组DNA的高通量测序,对这种抑制剂有抗性,揭示了大肠杆菌ung基因的破坏性突变,表明T5.015介导的生长抑制取决于Ung的尿嘧啶切除活性。我们验证了在不存在ung的情况下生长抑制被消除,并通过T5.015证实了Ung的物理结合。此外,使用T5.015和Ung的生化测定表明,T5.015介导由Ung的碱基切除活性产生的无碱基位点的核酸内切活性。重要的是,由核酸内切活性导致的生长抑制表现为DNA复制和细胞分裂停滞。我们推测噬菌体利用这种蛋白质选择性地导致宿主DNA的切割,比噬菌体拥有更多的尿嘧啶。这种蛋白质还可以增强噬菌体对感染细胞中可用资源的利用,因为停止复制可以节省核苷酸,停止细胞分裂可以维持分裂细胞的两个女儿。
    Bacteriophages (phages) have evolved efficient means to take over the machinery of the bacterial host. The molecular tools at their disposal may be applied to manipulate bacteria and to divert molecular pathways at will. Here, we describe a bacterial growth inhibitor, gene product T5.015, encoded by the T5 phage. High-throughput sequencing of genomic DNA of bacterial mutants, resistant to this inhibitor, revealed disruptive mutations in the Escherichia coli ung gene, suggesting that growth inhibition mediated by T5.015 depends on the uracil-excision activity of Ung. We validated that growth inhibition is abrogated in the absence of ung and confirmed physical binding of Ung by T5.015. In addition, biochemical assays with T5.015 and Ung indicated that T5.015 mediates endonucleolytic activity at abasic sites generated by the base-excision activity of Ung. Importantly, the growth inhibition resulting from the endonucleolytic activity is manifested by DNA replication and cell division arrest. We speculate that the phage uses this protein to selectively cause cleavage of the host DNA, which possesses more misincorporated uracils than that of the phage. This protein may also enhance phage utilization of the available resources in the infected cell, since halting replication saves nucleotides, and stopping cell division maintains both daughters of a dividing cell.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    Vast evolutionary distances separate the known herpesviruses, adapted to colonise specialised cells in predominantly vertebrate hosts. Nevertheless, the distinct herpesvirus families share recognisably related genomic attributes. The taxonomic Family Herpesviridae includes many important human and animal pathogens. Successful antiviral drugs targeting Herpesviridae are available, but the need for reduced toxicity and improved efficacy in critical healthcare interventions invites novel solutions: immunocompromised patients presenting particular challenges. A conserved enzyme required for viral fitness is Ung, a uracil-DNA glycosylase, which is encoded ubiquitously in Herpesviridae genomes and also host cells. Research investigating Ung in Herpesviridae dynamics has uncovered an unexpected combination of viral co-option of host Ung, along with remarkable Subfamily-specific exaptation of the virus-encoded Ung. These enzymes apparently play essential roles, both in the maintenance of viral latency and during initiation of lytic replication. The ubiquitously conserved Ung active site has previously been explored as a therapeutic target. However, exquisite selectivity and better drug-like characteristics might instead be obtained via targeting structural variations within another motif of catalytic importance in Ung. The motif structure is unique within each Subfamily and essential for viral survival. This unique signature in highly conserved Ung constitutes an attractive exploratory target for the development of novel beneficial therapeutics.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

       PDF(Pubmed)

公众号